AQNEURSA
NDC 83853-101, levacetylleucine, granule, for suspension, from IntraBio Inc.
- Product NDC
- 83853-101
- Status
- Listed
- Labeler
- IntraBio Inc
- Dosage form
- GRANULE, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219132
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83853-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVACETYLLEUCINE1000 mg/1
Pharmacologic classes
Bile Salt Export Pump Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83853-101-01 | 83853010101 | 28 PACKET in 1 CARTON (83853-101-01) / 1 GRANULE, FOR SUSPENSION in 1 PACKET |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0f248e55-d1bb-13f9-e063-6294a90a05ce
Use it
Look up 83853-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83853-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83853-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.